Literature DB >> 26111992

Synthesis and evaluation of galacto-noeurostegine and its 2-deoxy analogue as glycosidase inhibitors.

Stéphane Salamone1, Lise L Clement, Agnete H Viuff, Ole Juul Andersen, Frank Jensen, Henrik H Jensen.   

Abstract

An epimer of the known glycosidase inhibitor noeurostegine, galacto-noeurostegine, was synthesised in 21 steps from levoglucosan and found to be a potent, competitive and highly selective galactosidase inhibitor of Aspergillus oryzae β-galactosidase. Galacto-noeurostegine was not found to be an inhibitor of green coffee bean α-galactosidase, yeast α-glucosidase and E. coli β-galactosidase, whereas potent but non-competitive inhibition against sweet almond β-glucosidase was established. The 2-deoxy-galacto-noeurostegine analogue was also prepared and found to be a less potent inhibitor of the same enzymes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26111992     DOI: 10.1039/c5ob01062d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  1 in total

1.  The Bicyclic Form of galacto-Noeurostegine Is a Potent Inhibitor of β-Galactocerebrosidase.

Authors:  Agnete Viuff; Stéphane Salamone; Joseph McLoughlin; Janet E Deane; Henrik H Jensen
Journal:  ACS Med Chem Lett       Date:  2020-12-18       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.